AS per what Dr Cowens words on the 17th March at the conference...

AS per what Dr Cowens words on the 17th March at the conference call, all trials have provisions to be stopped , It may become unethical to deny those patients in the control arm the therapy should those the treatment arm are doing so well , there is a very good chance when we head for the 100 patients enrolled this will become obvious to the trial investigators , yet another alpha buying opportunity presents itself, good luck investors